• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New inhibitors of human cytomegalovirus (HCMV) on the horizon.

作者信息

De Clercq Erik

机构信息

Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium.

出版信息

J Antimicrob Chemother. 2003 May;51(5):1079-83. doi: 10.1093/jac/dkg205. Epub 2003 Apr 14.

DOI:10.1093/jac/dkg205
PMID:12697653
Abstract
摘要

相似文献

1
New inhibitors of human cytomegalovirus (HCMV) on the horizon.新型人类巨细胞病毒（HCMV）抑制剂即将出现。
J Antimicrob Chemother. 2003 May;51(5):1079-83. doi: 10.1093/jac/dkg205. Epub 2003 Apr 14.
2
Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.人巨细胞病毒对抗病毒药物的耐药性：诊断、监测及临床影响。
J Antimicrob Chemother. 2003 Sep;52(3):324-30. doi: 10.1093/jac/dkg354. Epub 2003 Jul 29.
3
Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR.通过实时PCR快速测定人巨细胞病毒的抗病毒药物敏感性
Antiviral Res. 2009 Jan;81(1):64-7. doi: 10.1016/j.antiviral.2008.09.009. Epub 2008 Nov 6.
4
Cytomegalovirus resistance testing: pitfalls and problems for the clinician.巨细胞病毒耐药性检测：临床医生的陷阱和问题。
Clin Infect Dis. 2010 Mar 1;50(5):733-6. doi: 10.1086/650463.
5
Differential resistance to antiviral drugs in an immunocompromised patient with cytomegalovirus encephalitis.一名患有巨细胞病毒性脑炎的免疫功能低下患者对抗病毒药物的耐药性差异
J Clin Virol. 2010 Nov;49(3):223-4. doi: 10.1016/j.jcv.2010.07.023. Epub 2010 Aug 30.
6
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.抗疟疾药物青蒿琥酯在体外和体内均可抑制巨细胞病毒的复制。
Antiviral Res. 2006 Feb;69(2):60-9. doi: 10.1016/j.antiviral.2005.10.003. Epub 2005 Nov 21.
7
Human cytomegalovirus DNA replication: antiviral targets and drugs.人巨细胞病毒DNA复制：抗病毒靶点与药物
Rev Med Virol. 2008 May-Jun;18(3):177-210. doi: 10.1002/rmv.558.
8
Antiviral strategies to combat cytomegalovirus infections in transplant recipients.对抗移植受者巨细胞病毒感染的抗病毒策略。
Curr Opin Pharmacol. 2008 Oct;8(5):541-8. doi: 10.1016/j.coph.2008.07.002. Epub 2008 Aug 25.
9
Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.吡咯烷-5,5'-反式内酰胺（5-氧代-六氢吡咯并[3,2 - b]吡咯）作为人巨细胞病毒蛋白酶新型基于机制的抑制剂的设计与合成。4. 抗病毒活性和血浆稳定性。
J Med Chem. 2003 Oct 9;46(21):4428-49. doi: 10.1021/jm030810w.
10
Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.巨细胞病毒抗病毒耐药性与治疗诱导的 UL97（蛋白激酶）和 UL54（DNA 聚合酶）突变相关。
J Med Virol. 2004 Sep;74(1):85-93. doi: 10.1002/jmv.20150.

引用本文的文献

1
Research for Cytomegalovirus Mutations Associated With Resistance to Antivirals in Kidney Transplant Receptors.研究巨细胞病毒突变与肾移植受者抗病毒药物耐药性的关系。
Cell Transplant. 2023 Jan-Dec;32:9636897231195245. doi: 10.1177/09636897231195245.
2
Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential.人巨细胞病毒与癌症：HCMV 诱导致癌的机制及其治疗潜力。
Front Cell Infect Microbiol. 2023 Jun 23;13:1202138. doi: 10.3389/fcimb.2023.1202138. eCollection 2023.
3
Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses.
抗病毒药物的现状与策略：第一部分：DNA病毒和逆转录病毒
Adv Antivir Drug Des. 2007;5:1-58. doi: 10.1016/S1075-8593(06)05001-5. Epub 2007 Sep 2.
4
Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?科威特肾移植患者接受抗病毒预防和治疗后巨细胞病毒会产生耐药性吗？
Adv Virol. 2011;2011:260561. doi: 10.1155/2011/260561. Epub 2011 Mar 24.
5
Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.构建对靶向巨细胞病毒酶的药物敏感的嵌合RB69 DNA聚合酶。
J Biol Chem. 2009 Sep 25;284(39):26439-46. doi: 10.1074/jbc.M109.012500. Epub 2009 Jul 21.
6
Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir.人巨细胞病毒UL97激酶在病毒感染中的作用及其受马里巴韦的抑制作用
Rev Med Virol. 2009 Jul;19(4):215-29. doi: 10.1002/rmv.615.
7
Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure.以磺胺为先导结构开发的无环氮杂核苷的合成及抗病毒评价
Bioorg Med Chem. 2008 Sep 15;16(18):8379-89. doi: 10.1016/j.bmc.2008.08.041. Epub 2008 Aug 26.
8
Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay.建立一种基于细胞的检测方法，用于筛选抑制巨细胞病毒复制周期极早期事件的化合物，并对使用该检测方法鉴定出的一种化合物进行表征。
Antimicrob Agents Chemother. 2008 Jul;52(7):2420-7. doi: 10.1128/AAC.00134-08. Epub 2008 May 5.
9
Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.人类巨细胞病毒成熟蛋白酶装配素及其前体（pPR，pUL80a）的酶活性相当：[已修正]pPR的最大活性需要通过其支架结构域进行自我相互作用。
J Virol. 2007 Apr;81(8):4091-103. doi: 10.1128/JVI.02821-06. Epub 2007 Feb 7.
10
Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.用于高通量筛选人巨细胞病毒蛋白酶抑制剂的新型酵母细胞检测法。
Antimicrob Agents Chemother. 2006 Feb;50(2):565-71. doi: 10.1128/AAC.50.2.565-571.2006.